Affiliate disclosure: Some links in this article are affiliate links. We may earn a commission at no additional cost to you.

Medical disclaimer: This article is for informational purposes only. It is not medical advice, diagnosis, or treatment. Not medical advice. Consult a qualified healthcare professional before changing your exercise habits, particularly if you have cardiovascular, musculoskeletal, or other health conditions.

TL;DR

• The 10,000-steps-per-day target originated in Japan in 1964 as the product name of a pedometer — not from mortality research or a clinical threshold.
• A 2022 harmonized analysis of 15 prospective cohorts (Paluch et al., Lancet Public Health) found all-cause mortality risk inversely associated with daily steps, with the mortality reduction appearing to plateau around 6,000–8,000 steps per day for adults aged 60 and over and somewhat higher for adults under 60.
• Japan’s Ministry of Health, Labour and Welfare national survey data places average adult daily steps in the 6,000–7,500 range depending on age group — below the 10,000-step target the same ministry officially promotes.
• Physical activity data from large Japanese cohorts, including the Japan Public Health Center-based Prospective Study (JPHC), is consistent with the international pattern: participants with low daily walking volume show higher all-cause and cardiovascular mortality risk relative to those with moderate-to-high activity.
• The mortality benefit in cohort data appears concentrated in the transition from low step counts (under 4,000–5,000) to moderate ones (6,000–8,000). The additional benefit of going from 8,000 to 10,000 steps is smaller, particularly in older adults.

Where the 10,000-step target came from — and why the origin matters

In 1964, a Japanese clockmaker and instrument manufacturer called Yamasa Tokei Instrument Co. launched a pedometer called the 万歩計 (Manpo-kei). The name translates directly as “ten-thousand-step meter.” The device debuted in the months surrounding the Tokyo Olympics, a moment of intense national interest in physical fitness and mass participation in sport.

The 10,000-step target embedded in the product name was not derived from population studies or clinical endpoints. No research had established 10,000 as a mortality threshold. The number was round, culturally resonant, and easy to remember — which is what made it useful as a product name and, eventually, as a health promotion slogan.

That origin does not make 10,000 steps a harmful goal. Behavioral targets often work well precisely because they are memorable and clear. But it does mean the specific number holds no privileged position in the evidence base. When research does locate a step-count range associated with meaningful mortality reduction, the answer does not reliably land on 10,000 — and knowing this shapes how to read both the research and the wellness content that cites it.

What the mortality data actually shows

The most comprehensive step-count and mortality synthesis published to date is a 2022 harmonized analysis by Paluch and colleagues in Lancet Public Health. The investigators pooled individual-level data from 15 prospective cohort studies across multiple countries, covering approximately 47,000 adults with a median follow-up of about 7 years.

The central finding: daily step count is inversely associated with all-cause mortality across all adult age groups studied. But the dose-response curve has a recognizable shape. For adults aged 60 and over, the mortality reduction appeared to plateau around 6,000–8,000 steps per day. The steepest part of the curve — where an increment of steps was associated with the most pronounced mortality reduction — fell in the range from very low activity (under 3,000–4,000 steps) to moderate activity (around 7,000 steps). For adults under 60, the plateau extended somewhat higher, into the 8,000–10,000 range.

A 2019 analysis by Lee and colleagues in JAMA Internal Medicine, which followed roughly 17,000 older US women (mean age 72) over a median of 4.3 years, found similar results: mortality benefit accrued with increasing steps up to approximately 7,500 steps per day, with no statistically significant additional reduction above that threshold in this older age group. Steps were measured with accelerometers rather than self-report, which reduces the measurement error that affects questionnaire-based physical activity data.

Saint-Maurice and colleagues, reporting in JAMA Internal Medicine in 2020 using NHANES-linked mortality data from a US representative sample of adults aged 40 and over, found that participants taking 8,000 or more daily steps had substantially lower all-cause mortality risk than those taking approximately 4,000. The comparison group taking 12,000 steps showed further but smaller reductions relative to 8,000.

Three things these studies do not establish:

Causal direction. People who are healthier walk more steps. Even with statistical adjustment for baseline chronic disease, cardiovascular risk factors, and functional status, residual confounding cannot be eliminated in observational cohort data. The biological plausibility of walking volume reducing mortality risk is strong — the mechanistic pathways through cardiovascular fitness, metabolic function, and adiposity are well-established — but cohort data cannot assign causality with the same confidence as randomized trials.

A single universal number. The dose-response relationship varies by age, sex, baseline fitness, and health status. The plateau around 7,000–8,000 steps observed in older adults does not apply without modification to working-age adults or to people with significantly elevated cardiovascular risk at baseline.

Equivalence of all walking. Walking pace adds predictive weight beyond step volume in several analyses. Brisk walking is associated with lower cardiovascular mortality independently of step count — meaning two people taking 7,000 steps at very different paces show different cardiovascular risk profiles in the evidence. The step-count frame captures volume; it does not capture intensity.

Japan’s actual walking data

Japan’s Ministry of Health, Labour and Welfare (厚労省) collects national physical activity data through the annual National Health and Nutrition Survey (国民健康栄養調査). The 2022 edition placed average daily steps for Japanese adults at roughly:

• Men aged 20–64: approximately 7,500–8,000 steps
• Men aged 65 and over: approximately 5,500–6,500 steps
• Women aged 20–64: approximately 6,500–7,000 steps
• Women aged 65 and over: approximately 4,500–5,500 steps

These figures fall short of Japan’s official walking target of 8,000–10,000 steps for working-age adults under the Healthy Japan 21 (Phase 3) framework. The ministry has noted in its reporting that average adult walking levels declined from the late 1990s through the 2010s before stabilizing, with increased sedentary time at desks and during commutes partially offsetting incidental transit-linked walking.

NHK survey reporting and the ministry’s time-use data consistently show that Japanese adults rely heavily on incidental walking — station transfers, walkable neighborhood errands — rather than dedicated exercise sessions. Commuters transferring through major stations in Tokyo or Osaka often accumulate 2,000–4,000 steps per commute leg from platform navigation alone, without any deliberate exercise intent. This is a feature of transit-oriented urban design that car-dependent cities do not produce.

Physical activity data from the Japan Public Health Center-based Prospective Study (JPHC), which has tracked more than 100,000 Japanese adults across 11 public health center areas since 1990, has found walking time and physical activity inversely associated with all-cause and cardiovascular mortality in Japanese adult populations. The JPHC findings are observational and face the same confounding concerns as international cohort data; their value is confirming that the directionality seen in international analyses holds in a large Japanese-population sample. Low-walking participants in JPHC analyses consistently show elevated risk relative to more active groups.

What type of walking the evidence addresses — and what it does not

The step-count literature focuses on volume. A separate body of research, much of it conducted in Japan, examines whether the setting or type of walking adds effects beyond the steps themselves.

Shinrin-yoku (森林浴 — forest bathing) research, developed largely through work by the Nippon Medical School group and Yoshifumi Miyazaki’s lab at Chiba University, has found that walking in forest environments, compared to equivalent-distance walking in urban settings, is associated with lower salivary cortisol, reduced blood pressure, and improved natural killer cell counts in a series of Japanese studies published between 2005 and 2018. The studies are consistently small (typically 10–20 participants) and the endpoints are biomarker-level rather than mortality outcomes. The directionality has been consistent enough to sustain a funded research program; the study sizes are too small to support strong clinical conclusions. For the full evidence picture on forest bathing, see our shinrin-yoku evidence overview.

Nordic walking — with poles, which engages upper body musculature and allows higher intensity at equivalent perceived effort — has a small evidence base for cardiovascular fitness benefits exceeding flat-surface walking, particularly in older adult cohorts and cardiac rehabilitation settings. It is most relevant for populations where joint impact concerns constrain pace.

Walking in Japan as a travel structure

Japan offers several environments where high daily step counts occur naturally as a byproduct of the activity rather than as a target to track.

The Kumano Kodo pilgrimage routes in the Kii Peninsula are a UNESCO World Heritage Site consisting of trail networks originally used by aristocratic pilgrims traveling to the Kumano Grand Shrines. Modern walkers covering the main Nakahechi section — roughly the route between Tanabe and the three Grand Shrines — typically accumulate 15,000–25,000 steps per day over multiple stages. The walking is sustained, at low-to-moderate intensity, on varied terrain with significant elevation change, and structured around a cultural and historical framework that creates natural motivation to complete each stage.

The Nakasendo route between Tokyo and Kyoto, the castle-town walking circuits in Kanazawa and Kyotango, and organized city heritage walks in Kyoto, Nara, and Kamakura produce similar structural conditions: high daily step counts as a byproduct of experiencing what the place has to offer, rather than as an exercise session with a step goal.

Klook lists guided and self-guided walking programs across Japan — day-hike circuits, half-day heritage walks, and multi-day trail packages — that provide a framework for structuring high-step travel without requiring independent route planning in rural or mountainous terrain.

For a basic pedometer to track daily steps during Japan travel without relying on a smartphone or subscription service, Omron and Yamasa step counters on Amazon are the domestic Japanese brands with the longest market history in this category and are available internationally through the US storefront.

What the evidence supports — and what it does not

Several positions hold up under the available data:

• The 10,000-step target has no special evidential status. It originated in a product name. This does not make it a bad behavioral goal; round memorable targets can motivate behavior change. But there is no threshold finding that places 10,000 specifically at a mortality breakpoint.
• Daily step count is inversely associated with all-cause mortality in multiple large prospective cohorts including Japanese-population data. The association is consistent and biologically plausible, though causal inference from observational data requires caution.
• For adults over 60, the mortality benefit appears to concentrate in moving from low to moderate step counts (roughly 4,000 to 7,000 steps). The additional benefit beyond 7,000–8,000 steps is smaller in this age group. For adults under 60, the curve extends higher before flattening.
• Japan’s average adult walking is already in the range associated with meaningful mortality reduction in cohort data. The policy gap — between average actual steps and the 10,000-step target — is real, but the mortality implications of that gap are smaller than wellness content typically implies.
• Walking pace adds independent cardiovascular risk information beyond step volume. Moderate-to-brisk walking at 7,000 steps is not equivalent to slow walking at 7,000 steps in every health dimension.

For the broader context of how Japanese longevity researchers situate physical activity alongside sleep, diet, and social connection, see the Japanese centenarian daily habits summary from NHK’s 2026 documentary series and the sleeping habits and JACC cohort data overview. The relevant pattern in that literature is that single behavioral variables — a step count target, a specific sleep duration — consistently underfit what the cohort data shows. Physical activity, sleep architecture, diet quality, and social structure appear to function together, not in isolation.

If you have cardiovascular disease, a recent orthopedic injury, or conditions affecting gait stability or balance, speak with a physician before significantly increasing your daily walking volume.

---

Sources: Paluch AE, et al. “Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts.” Lancet Public Health. 2022;7(3):e219–e228. Lee I-M, et al. “Association of Step Volume and Intensity With All-Cause Mortality in Older Women.” JAMA Internal Medicine. 2019;179(8):1105–1112. Saint-Maurice PF, et al. “Association of Daily Step Count and Step Intensity With Mortality Among US Adults.” JAMA Internal Medicine. 2020;180(8):1151–1153. Ministry of Health, Labour and Welfare Japan, National Health and Nutrition Survey 2022 (国民健康栄養調査). Japan Public Health Center-based Prospective Study (JPHC Study): jphc.ncc.go.jp. Miyazaki Y, et al. Forest bathing and physiological responses (multiple publications, Chiba University, 2005–2018). Healthy Japan 21 (第三次) framework documentation, MHLW.